Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 or older
- People with moderate-to-severe ulcerative colitis, measured using a standard scoring system called the clinical Mayo score (a score above 6, with an endoscopic — camera examination — score of 2 or 3)
- People with moderate-to-severe Crohn's disease, measured using standard scoring tools (a Crohn's Disease Activity Index score above 220, and a bowel camera examination score of 7 or higher)
- People currently being treated with one of these medications: adalimumab, infliximab, ustekinumab, or vedolizumab
- People who have been on their current biologic medication for between 6 weeks and 12 months
- People who have never previously received a biologic medication
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously been treated with a biologic medication before the current one
- People whose medical records are incomplete or missing important treatment or outcome information
- People taking another biologic medication or small-molecule therapy at the same time for another condition, such as a rheumatological (joint or immune system) disease
- People who are pregnant
- People who had gaps or breaks in their treatment during the 12-month period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mohamed Abaas Sabah, Professor, Assiut University
Phone: +20 1555227403
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Efficacy of different biological treatment on patient with inflammatory bowel disease after one year of treatment in upper egypt
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.